TIRZEPATIDE IN Houston, TX

Just $479/month

Tirzepatide Medical Weight Loss in Houston, Texas

Tirzepatide is a medication known as a dual agonist. Similar to Semaglutide, Tirzepatide is a GLP-1 agonist. However, the difference in the two is that Tirzepatide is also GIP. Because it works on two separate receptors, Tirzepatide may be a better option for those looking to lose more weight. Tirzepatide is administered via weekly injections at one of Huemn’s convenient Houston-area locations.

the process:

READY TO GET STARTED?

Fill out the form and we’ll be in touch ASAP. Once you complete the form, you will be redirected to our Thank You page that has our Patient Intake Waiver linked. Feel free to fill out the form to access our Medical Director’s appointment schedule.

benefits of TIRZEPATIDE at huemn

There are a myriad of benefits of Tirzepatide, but some of the major ones include:

  • Helps you lose weight

  • Improves insulin resistance

  • Reduces atherosclerosis

  • May help combat inflammation

  • May improve gut microbiome

semagluetide at Huemn for weightloss

how TIRZEPATIDE therapy works

Tirzepatide is a novel glucose-lowering agent that works by mimicking the effects of two incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

  1. GLP-1: This hormone enhances the secretion of insulin from the pancreas in a glucose-dependent manner, which means its main purpose is to stimulate insulin release when blood sugar levels are high. GLP-1 also suppresses glucagon secretion (which otherwise would raise blood glucose levels), slows gastric emptying (which helps prevent a rapid rise in blood glucose after meals), and reduces food intake by increasing satiety.

  2. GIP: This hormone also promotes insulin secretion in response to food intake but has been thought to have a less prominent role than GLP-1. However, recent research suggests that GIP may also play a beneficial role in the control of blood glucose levels.

the SCIENCE OF TIRZEPATIDE therapy:

Tirzepatide for Weight Loss in Adults with Obesity: Injections once weekly provided substantial and sustained reductions in body weight.

Tirzepatide vs. Semaglutide Once Weekly in Patients with Type 2 Diabetes: In patients with type 2 diabetes, tirzepatide was noninferior and superior to semaglutide with respect to the mean change in the glycated hemoglobin level from baseline to 40 weeks.

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes: Tirzepatide improved markers of IS and beta-cell function to a greater extent than dulaglutide. IS effects of tirzepatide were only partly attributable to WL, suggesting dual receptor agonism confers distinct mechanisms of glycemic control.

Tirzepatide Trial Demonstrates Substantial Weight Loss: Participants experienced substantial and sustained weight loss with a weekly injection of the novel glucose-dependent insulinotropic polypeptide and glucagon–like peptide-1 receptor agonist, which is approved for type 2 diabetes.

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: Adults participating in a 12-week lifestyle intervention followed by 72 weeks of tirzepatide lost a mean 24.3% of their body weight. Nearly 45% of adults achieved weights loss of 20% or greater with Tirzepatide.

FAQS

What is Tirzepatide?

Tirzepatide is a prescription injection that aids in the weight loss process. Tirzepatide mimicks the effects of a naturally occurring gut hormones called GLP-1 and GIP, which helps to regulate blood sugar levels in the body.

How does Tirzepatide work?

Tirzepatide is a dual agonist, meaning it works on two receptors in the body, GLP-1 and GIP. This medication slows down the rate at which your stomach sends food to your large intestine. This results in slower digestion (which improves blood sugar) and a longer feeling of fullness. It also stimulates the pancreas to produce more insulin, removing sugar from the bloodstream.

Who is a candidate for Tirzepatide?

Virtually anyone who has weight to lose can be a candidate for Tirzepatide injections. There are a few contraindications that are covered in our waiver (and detailed below).

Who is not a candidate for Tirzepatide?

Tirzepatide is not recommended for anyone who has a history of medullary thyroid carcinoma (a rare form of thyroid cancer), or a condition called Multiple Endocrine Neoplasia syndrome type 2. Additionally, Tirzepatide is not recommended for those with Type 1 Diabetes.

Is Tirzepatide safe?

Tirzepatide has undergone years of rigorous clinical trials and has been shown to be safe in a wide variety of populations.

What are the potential side effects of Tirzepatide?

Tirzepatide may cause side effects such as nausea, diarrhea, and vomiting. However, the risk of these side effects is generally considered to be low, and most people are able to tolerate the medication well. Typically, side effects of Tirzepatide improve after the first four weeks of therapy.

How often do I need to come in for injections?

You will be on a weekly injection schedule. Injections are administered by our staff at Huemn (both locations). It is recommended that injections take place on the same day every week.

How long is the Tirzepatide program at Huemn?

The initial program commitment is 3 months, with many staying on a maintenance dose after reaching their goal weight.

How much does it cost?

The initial consultation with our doctor costs $99. After you receive approval for the treatment, you will be enrolled in our program that costs $479/month. This includes the cost of your prescription and four injections per month.

Are there any dietary or exercise restrictions?

No, there are no restrictions. While it is encouraged that you eat a balanced diet, there are no dietary restrictions with Semaglutide therapy. Additionally, exercise is encouraged and there are no exercise restrictions while in our program.

Disclaimer: The statements and content presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). We do not diagnose, treat, or claim to treat any health conditions. All services provided by Huemn are intended solely to promote overall wellness, and information on this site is published for educational purposes. Always consult with a healthcare professional before making any decisions related to your health.